Showing 1421-1430 of 2235 results for "".
- Cutera Invites ASLMS Attendees to Celebrate AviClear Launchhttps://modernaesthetics.com/news/cutera-invites-aslms-attendees-to-celebrate-aviclear-launch/2473222/Cutera is celebrating the launch of AviClear during the ASLMS meeting in San Diego, and meeting attendees are invited to join the festivities. AviClear is the first and only FDA cleared energy-based device for the treatment of mild, moderate, and severe acne, The AviClear laun
- Suneva's Silhouette InstaLift Recognized with New Beauty Awardhttps://modernaesthetics.com/news/sunevas-silhouette-instalift-recognized-with-new-beauty-award/2473219/Suneva Medical, Inc.'s non-surgical thread lift, Silhouette InstaLift®, is the Best Thread Lift Treatment in NewBeauty's 2022 Beauty Awards. It uses collagen-stimulating absorbable sutures that offer patients immediate and lasting results with minimal recovery time.
- Jeune Aesthetics Shares Positive Clinical Phase 1 Data for Investigational Gene-based Treatment to Address the Underlying Biology of Aging Skinhttps://modernaesthetics.com/news/jeune-aesthetics-shares-positive-clinical-phase-1-data-for-investigational-gene-based-treatment-to-address-the-underlying-biology-of-aging-skin/2473210/Jeune Aesthetics, Inc., a wholly-owned subsidiary of Krystal Biotech, Inc. shared positive proof-of-concept efficacy data from Cohort 2 of its PEARL-1 study of KB301, Jeune Aesthetics’ lead candidate for the treatment of aesthetic skin conditions. “We are pleased to see
- The Beauty Health Company Introduces HydraFacial Syndeo Delivery Systemhttps://modernaesthetics.com/news/the-beauty-health-company-introduces-hydrafacial-syndeo-delivery-system/2473205/The Beauty Health Company is rolling out the HydraFacial Syndeo, a digital device that aims to enhance the consumer and provider experience. “As a category creator, we deliver beauty health experiences every day that re-invent our consumer’s relationship with their ski
- Business News: Solta Medical Readies for IPOhttps://modernaesthetics.com/news/business-news-solta-medical-readies-for-ipo/2473195/Bausch Subsidiary Solta Medical Corporation is getting ready to go public. The Company publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering ("IPO") of Solta's common shares.
- Meet Radiesse (+) from Merz: The First and Only Aesthetic Injectable for Jawline Contourhttps://modernaesthetics.com/news/meet-radiesse-from-merz-the-first-and-only-aesthetic-injectable-for-jawline-contour/2473190/Merz Aesthetics is launching Radiesse (+) Lidocaine for jawline contouring in adults over the age of 21. Radiesse (+) is the first and only U.S. Food and Drug Administration (FDA)-approved injectable treatment for jawline contour improvement. The FDA approved the supplemental
- Crown Laboratories Joins Global Movement to Increase Accurate Media Portrayals of Women and Girlshttps://modernaesthetics.com/news/crown-laboratories-joins-global-movement-to-increase-accurate-media-portrayals-of-women-and-girls/2473186/Crown Laboratories, Inc. is joining SeeHer, a movement to increase accurate portrayals of women and girls in advertising and media, In partnership with the SeeHer movement and via its membership with the Association of National Advertisers, Crown will work to further promote t
- FDA Approves Mentor MemoryGel BOOST Breast Implanthttps://modernaesthetics.com/news/fda-approves-mentor-memorygel-boost-breast-implant/2473184/The Mentor® MemoryGel BOOST™ Breast Implant is now FDA approved for breast augmentation in women at least 22-years-old, and for women of all ages undergoing breast reconstruction. The product from Me
- Avita Medical Inc. Shares Preclinical Data, Completes Enrollment in Pivotal Soft Tissue Reconstruction Trialhttps://modernaesthetics.com/news/avita-medical-inc-shares-preclinical-data-completes-enrollment-in-pivotal-soft-tissue-reconstruction-trial/2473181/Preclinical data successfully established proof of concept for Spray-On Skin™ Cells therapy from Avita Medical, Inc. in skin rejuvenation and epidermolysis bullosa, two key areas of cell-based gene therapy. Researchers at the Houston Methodist Research Institute (HMRI) partne
- Done Deal: RoundTable Healthcare Partners Completes Sale of Revision Skincare and Goodier Cosmetics to Gryphon Investorshttps://modernaesthetics.com/news/done-deal-roundtable-healthcare-partners-completes-sale-of-revision-skincare-and-goodier-cosmetics-to-gryphon-investors/2473172/RoundTable Healthcare Partners completed the previously announced sale of Revision Skincare and Goodier Cosmetics to Gryphon Investors. Terms of the transaction were not disclosed. Revision Skincare’s portfolio includes Nectifirm, Intellishade, D·E·J